This article was originally published in The Tan Sheet
President Patrick Toomey asks that the House Appropriations/Labor-HHS Subcommittee direct the Agency for Healthcare Research and Quality to work with NIH's Office of Dietary Supplements and National Center for Complementary & Alternative Medicine in "developing cost-effectiveness projects designed to compare the value of herbs and other dietary supplements in the treatment and prevention of chronic illness to typical medical approaches." At the March 14 hearing, the association head also urges increased funding for both ODS and NCCAM
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC